Onychomycosis in systemic lupus erythematosus: A case control study

Journal of Rheumatology

Volumn 30, Issue 7, 2003, Pages 1491-1494

  Tlacuilo Parra, Alberto ^a   Guevara Gutierrez, Elizabeth ^a   Mayorga, Jorge ^a   Garcia De La Torre, Ignacio ^a   Salazar Paramo, Mario ^a  

^a NONE

Author keywords

Dermatophytosis; Immunodeficiency; Onychomycosis; Systemic lupus erythematosus

Indexed keywords

CICLOPIROX; FLUCONAZOLE; ITRACONAZOLE; NAFTIFINE; TERBINAFINE;

ADULT; AGED; ARTICLE; CASE CONTROL STUDY; CLINICAL ARTICLE; DERMATOMYCOSIS; DISEASE ASSOCIATION; FEMALE; FUNGUS IDENTIFICATION; HUMAN; IMMUNE DEFICIENCY; IMMUNOCOMPETENCE; MALE; ONYCHOMYCOSIS; POPULATION RESEARCH; PREVALENCE; PRIORITY JOURNAL; SAMPLING; SYSTEMIC LUPUS ERYTHEMATOSUS; TRICHOPHYTON RUBRUM;

ADOLESCENT; ADULT; AGED; CASE-CONTROL STUDIES; FEMALE; FOOT DERMATOSES; FUNGI; HUMANS; IMMUNOCOMPROMISED HOST; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; MIDDLE AGED; ONYCHOMYCOSIS; PREVALENCE;

EID: 0037491613     PISSN: 0315162X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Ramesh V, Reddy BSN, Singh R. Onychomycosis. Int J Dermatol 1983;22:148-52.
2. Achten G, Wanet-Rouard J. Onychomycosis in the laboratory. Mykosen 1987;21:125-7.
3. Zaias N. Onychomycosis. Arch Dermatol 1972;105:263-74.
4. Roberts DT. Prevalence of dermatophyte onychomycosis in United Kingdom: result of an omnibus survey. Br J Dermatol 1992;126 Suppl:39-42.
5. Evans EGV. Causative pathogens in onychomycosis and the possibility of treatment resistance. A review. J Am Acad Dermatol 1998;38:32-6.
6. Williams HC. The epidemiology of onychomycosis in Britain. Br J Dermatol 1993;129:101-9.
7. Gupta AK, Jain HC, Lynde CW, MacDonald P, Cooper EA, Summerbell RC. Prevalence and epidemiology of onychomycosis in patients visiting physicians' offices: A multicenter Canadian survey of 15,000 patients. J Am Acad Dermatol 2000;43:244-8.
8. Jain S, Sehgal VN. Onychomycosis: an epidemio-etiologic perspective. Int J Dermatol 2000;39:100-3.
9. Baran R, Hay RJ, Tosti A, Haneke E. A new classification of onychomycosis. Br J Dermatol 1998;139:567-71.
10. Summerbell RC. Epidemiology and ecology of onychomycosis. Dermatology 1997;194:32-6.
11. Sais G, Jucga A, Peyri J. Prevalence of dermatophyte onychomycosis in Spain: a cross-sectional study. Br J Dermatol 1995;133:758-61.
12. Chang P, Arenas R. Proximal white subungual onychomycosis in a kidney transplant patient [letter]. Int J Dermatol 1995;34:591.
13. Dompmartin D, Dompmartin A, Delmol AM. Onychomycosis and AIDS. Int J Dermatol 1990;29:377-9.
14. Gupta AK, Taborda P, Taborda V, et al. Epidemiology and prevalence of onychomycosis in HIV-positive individuals. Int J Dermatol 2000;39:746-53.
15. Urowitz MB, Gladman DD, Chalmers A, Ogryzlo MA. Nail lesions in systemic lupus erythematosus. J Rheumatol 1978;5:441-7.
16. Vaughn RY, Bailey JP, Jr., Field RS, et al. Diffuse nail dyschromia in black patients with systemic lupus erythematosus. J Rheumatol 1990;17:640-3.
17. Gupta AK, Jain HC, Lynde CW, Wattel GN, Summerbell RC. Prevalence of unsuspected onychomycosis in patients visiting dermatologists' offices in Ontario, Canada: a multicenter survey of 2001 patients. Int J Dermatol 1997;36:783-7.
18. Daniel CR III, Gupta AK, Daniel MP, Sullivan S. Candida infection of the nail: role of Candida as a primary or secondary pathogen. Int J Dermatol 1998;37:904-7.
19. Heikkila H, Stubb S. Prevalence of onychomycosis in Finland. Br J Dermatol 1995;133:699-703.
20. Aly R. Ecology and epidemiology of dermatophyte infections. J Am Acad Dermatol 1994:31 Suppl;21-25.
21. Midgley G, Moore MK, Cook JC, Phan QG. Mycology of nail disorders. J Am Acad Dermatol 1994;31 Suppl:68-74.
22. Lunder M, Lunder M. Is Microsporum canis infection about to become a serious dermatological problem? Dermatology 1992;184:87-9.
23. Svejgaard EL. Epidemiology of dermatophytes in Europe. Int J Dermatol 1995;34:525-8.
24. Elewski B. White subungual onychomycosis. J Am Acad Dermatol 1993;29:631-2.
25. Tlacuilo-Parra A, Guevara-Gutierrez E, Mayorga J, Salazar-Paramo M. Proximal white subungual onychomycosis caused by Microsporum canis in systemic lupus erythematosus. Rheumatol Int 2002;21:250-2.
26. Havu V, Brandt H, Heikkila H, et al. A double-blind, randomized study comparing itraconazole pulse therapy with continuous dosing for the treatment of toe-nail onychomycosis. Br J Dermatol 1997;136:230-4.
27. Elewski B. Once-weekly fluconazole in the treatment of onychomycosis: Introduction. J Am Acad Dermatol 1998;38 Suppl:73-6.
28. Epstein E. How often does oral treatment of toenail onychomycosis produce a disease-free nail? An analysis of published data. Arch Dermatol 1998;134:1551-4.
29. Murphy M, Barnes L. Terbinafine-induced lupus erythematosus. Br J Dermatol 1998;138:708-9.
30. Brooke R, Coulson IH, Al-Dawoud A. Terbinafine-induced subacute cutaneous lupus erythematosus. Br J Dermatol 1998;139:1132-3.
31. Holmes S, Kemmett D. Exacerbation of systemic lupus erythematosus induced by terbinafine [letter]. Br J Dermatol 1998;139:1133.